U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757152) titled 'Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China' on Aug. 05. ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758335) titled 'The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757035) titled 'Effects of Low Frequency Whole Body Vibrations on Motor Skills and Sensory Integration in C... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... Read More
Singapore, Aug. 12 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More